Comparative evaluation of the protective efficacy of two formulations of a recombinant Chlamydia abortus subunit candidate vaccine in a mouse model
Highlights • The ability of recombinant C. abortus Pmp18D formulated in CpG + FL adjuvants or Vibrio cholerae ghosts (VCGs) to induce innate and cross protective immunity against genital C. abortus infection was evaluated. • VCG-delivered rPmp18D was more effective than CpG + FL in stimulating the D...
Saved in:
Published in: | Vaccine Vol. 33; no. 15; pp. 1865 - 1872 |
---|---|
Main Authors: | , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Netherlands
Elsevier Ltd
08-04-2015
Elsevier Limited |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Highlights • The ability of recombinant C. abortus Pmp18D formulated in CpG + FL adjuvants or Vibrio cholerae ghosts (VCGs) to induce innate and cross protective immunity against genital C. abortus infection was evaluated. • VCG-delivered rPmp18D was more effective than CpG + FL in stimulating the DC expression of molecules critically involved in T cell activation and differentiation, and activation of innate immune signaling involving TLRs and NLRP3 inflammasome. • VCG-delivered rPmp18D elicited more robust antigen-specific cellular and humoral immune responses in mice compared to CpG + FL. • Vaccine delivery with VCG induced superior cross-protective immunity than delivery with a combination of CpG1826 and FL. • The vaccine delivery and immunomodulatory capacity of VCG is thus superior to that of CpG + FL adjuvants. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0264-410X 1873-2518 |
DOI: | 10.1016/j.vaccine.2015.02.007 |